Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.41 USD 1.44% Market Closed
Market Cap: 131.8m USD

Intrinsic Value

CGEN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CGEN stock under the Base Case scenario is 1.44 USD. Compared to the current market price of 1.41 USD, Compugen Ltd is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGEN Intrinsic Value
1.44 USD
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Compugen Ltd

Valuation History Unavailable

Historical valuation for CGEN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Compugen Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Compugen Ltd

Current Assets 106m
Cash & Short-Term Investments 103.3m
Receivables 2.7m
Non-Current Assets 9m
Long-Term Investments 3.1m
PP&E 3.7m
Other Non-Current Assets 2.2m
Efficiency

Free Cash Flow Analysis
Compugen Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Compugen Ltd

Revenue
27.9m USD
Cost of Revenue
-7.9m USD
Gross Profit
19.9m USD
Operating Expenses
-34.8m USD
Operating Income
-14.9m USD
Other Expenses
660k USD
Net Income
-14.2m USD
Fundamental Scores

CGEN Profitability Score
Profitability Due Diligence

Compugen Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Exceptional Revenue Growth Forecast
30/100
Profitability
Score

Compugen Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

CGEN Solvency Score
Solvency Due Diligence

Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGEN Price Targets Summary
Compugen Ltd

Wall Street analysts forecast CGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEN is 4.85 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
187% Upside
Average
Price Target
4.85 USD
244% Upside
Highest
Price Target
7.35 USD
421% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Compugen Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CGEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CGEN stock?

The intrinsic value of one CGEN stock under the Base Case scenario is 1.44 USD.

Is CGEN stock undervalued or overvalued?

Compared to the current market price of 1.41 USD, Compugen Ltd is Undervalued by 2%.

Back to Top